ATE326862T1 - Oligosaccharide enthaltende ernährungszusammensetzungen - Google Patents

Oligosaccharide enthaltende ernährungszusammensetzungen

Info

Publication number: ATE326862T1
Authority: AT; Austria
Prior art keywords: lacto; compositions containing; nutritional compositions; containing oligosaccharides; fucopentaose
Prior art date: 1997-03-31

Application number

AT98912118T

Other languages

English (en)

Inventor

Pedro A Prieto

Stephen J Kirchner

Renee M Erney

Original Assignee

Abbott Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-03-31

Filing date

1998-03-30

Publication date

2006-06-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25253688&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE326862(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1998-03-30 Application filed by Abbott Lab filed Critical Abbott Lab

2006-06-15 Application granted granted Critical

2006-06-15 Publication of ATE326862T1 publication Critical patent/ATE326862T1/de

Links

239000000203 mixture Substances 0.000 title abstract 2
235000016709 nutrition Nutrition 0.000 title abstract 2
229920001542 oligosaccharide Polymers 0.000 title abstract 2
150000002482 oligosaccharides Chemical class 0.000 title abstract 2
229940062827 2'-fucosyllactose Drugs 0.000 abstract 1
HWHQUWQCBPAQQH-UHFFFAOYSA-N 2-O-alpha-L-Fucosyl-lactose Natural products OC1C(O)C(O)C(C)OC1OC1C(O)C(O)C(CO)OC1OC(C(O)CO)C(O)C(O)C=O HWHQUWQCBPAQQH-UHFFFAOYSA-N 0.000 abstract 1
HWHQUWQCBPAQQH-BWRPKUOHSA-N 2-fucosyllactose Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O HWHQUWQCBPAQQH-BWRPKUOHSA-N 0.000 abstract 1
AUNPEJDACLEKSC-ZAYDSPBTSA-N 3-fucosyllactose Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)O[C@H](CO)[C@@H]1O AUNPEJDACLEKSC-ZAYDSPBTSA-N 0.000 abstract 1
WJPIUUDKRHCAEL-UHFFFAOYSA-N 3FL Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(O)C(O)C(CO)O2)O)C(CO)OC(O)C1O WJPIUUDKRHCAEL-UHFFFAOYSA-N 0.000 abstract 1
TVVLIFCVJJSLBL-SEHWTJTBSA-N Lacto-N-fucopentaose V Chemical compound O[C@H]1C(O)C(O)[C@H](C)O[C@H]1OC([C@@H](O)C=O)[C@@H](C(O)CO)O[C@H]1[C@H](O)[C@@H](OC2[C@@H](C(OC3[C@@H](C(O)C(O)[C@@H](CO)O3)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](O)[C@@H](CO)O1 TVVLIFCVJJSLBL-SEHWTJTBSA-N 0.000 abstract 1
LKOHREGGXUJGKC-UHFFFAOYSA-N Lactodifucotetraose Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(O)C(O)OC2CO)OC2C(C(O)C(O)C(C)O2)O)OC(CO)C(O)C1O LKOHREGGXUJGKC-UHFFFAOYSA-N 0.000 abstract 1
AXQLFFDZXPOFPO-UHFFFAOYSA-N UNPD216 Natural products O1C(CO)C(O)C(OC2C(C(O)C(O)C(CO)O2)O)C(NC(=O)C)C1OC(C1O)C(O)C(CO)OC1OC1C(O)C(O)C(O)OC1CO AXQLFFDZXPOFPO-UHFFFAOYSA-N 0.000 abstract 1
SNFSYLYCDAVZGP-UHFFFAOYSA-N UNPD26986 Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(OC(O)C(O)C2O)CO)OC(CO)C(O)C1O SNFSYLYCDAVZGP-UHFFFAOYSA-N 0.000 abstract 1
FZIVHOUANIQOMU-YIHIYSSUSA-N alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-D-Glcp Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@@H]2[C@H]([C@H](O[C@@H]3[C@H]([C@H](O[C@@H]4[C@H](OC(O)[C@H](O)[C@H]4O)CO)O[C@H](CO)[C@@H]3O)O)O[C@H](CO)[C@H]2O)NC(C)=O)O[C@H](CO)[C@H](O)[C@@H]1O FZIVHOUANIQOMU-YIHIYSSUSA-N 0.000 abstract 1
LKOHREGGXUJGKC-GXSKDVPZSA-N alpha-L-Fucp-(1->3)-[alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)]-beta-D-Glcp Chemical compound C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]2O[C@@H]2[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]2O)[C@@H](O)[C@H](O)[C@@H]1O LKOHREGGXUJGKC-GXSKDVPZSA-N 0.000 abstract 1
CMQZRJBJDCVIEY-JEOLMMCMSA-N alpha-L-Fucp-(1->3)-[beta-D-Galp-(1->4)]-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-D-Glcp Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)[C@@H](CO)O[C@@H](O[C@@H]2[C@H]([C@H](O[C@@H]3[C@H](OC(O)[C@H](O)[C@H]3O)CO)O[C@H](CO)[C@@H]2O)O)[C@@H]1NC(C)=O CMQZRJBJDCVIEY-JEOLMMCMSA-N 0.000 abstract 1
DUKURNFHYQXCJG-JEOLMMCMSA-N alpha-L-Fucp-(1->4)-[beta-D-Galp-(1->3)]-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-D-Glcp Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)[C@@H](NC(C)=O)[C@H](O[C@@H]2[C@H]([C@H](O[C@@H]3[C@H](OC(O)[C@H](O)[C@H]3O)CO)O[C@H](CO)[C@@H]2O)O)O[C@@H]1CO DUKURNFHYQXCJG-JEOLMMCMSA-N 0.000 abstract 1
AXQLFFDZXPOFPO-UNTPKZLMSA-N beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-beta-D-Glcp Chemical compound O([C@@H]1O[C@H](CO)[C@H](O)[C@@H]([C@H]1O)O[C@H]1[C@@H]([C@H]([C@H](O)[C@@H](CO)O1)O[C@H]1[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O1)O)NC(=O)C)[C@H]1[C@H](O)[C@@H](O)[C@H](O)O[C@@H]1CO AXQLFFDZXPOFPO-UNTPKZLMSA-N 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
FZIVHOUANIQOMU-UHFFFAOYSA-N lacto-N-fucopentaose I Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(OC3C(C(OC4C(OC(O)C(O)C4O)CO)OC(CO)C3O)O)OC(CO)C2O)NC(C)=O)OC(CO)C(O)C1O FZIVHOUANIQOMU-UHFFFAOYSA-N 0.000 abstract 1
FKADDOYBRRMBPP-UHFFFAOYSA-N lacto-N-fucopentaose II Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(O)C(O)C(CO)O2)O)C(NC(C)=O)C(OC2C(C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C2O)O)OC1CO FKADDOYBRRMBPP-UHFFFAOYSA-N 0.000 abstract 1
CMQZRJBJDCVIEY-UHFFFAOYSA-N lacto-N-fucopentaose III Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(O)C(O)C(CO)O2)O)C(CO)OC(OC2C(C(OC3C(OC(O)C(O)C3O)CO)OC(CO)C2O)O)C1NC(C)=O CMQZRJBJDCVIEY-UHFFFAOYSA-N 0.000 abstract 1
IEQCXFNWPAHHQR-UHFFFAOYSA-N lacto-N-neotetraose Natural products OCC1OC(OC2C(C(OC3C(OC(O)C(O)C3O)CO)OC(CO)C2O)O)C(NC(=O)C)C(O)C1OC1OC(CO)C(O)C(O)C1O IEQCXFNWPAHHQR-UHFFFAOYSA-N 0.000 abstract 1
USIPEGYTBGEPJN-UHFFFAOYSA-N lacto-N-tetraose Natural products O1C(CO)C(O)C(OC2C(C(O)C(O)C(CO)O2)O)C(NC(=O)C)C1OC1C(O)C(CO)OC(OC(C(O)CO)C(O)C(O)C=O)C1O USIPEGYTBGEPJN-UHFFFAOYSA-N 0.000 abstract 1
229940062780 lacto-n-neotetraose Drugs 0.000 abstract 1
RBMYDHMFFAVMMM-PLQWBNBWSA-N neolactotetraose Chemical compound O([C@H]1[C@H](O)[C@H]([C@@H](O[C@@H]1CO)O[C@@H]1[C@H]([C@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)O[C@H](CO)[C@@H]1O)O)NC(=O)C)[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O RBMYDHMFFAVMMM-PLQWBNBWSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S426/00—Food or edible material: processes, compositions, and products
- Y10S426/801—Pediatric

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Polymers & Plastics (AREA)
Nutrition Science (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Food Science & Technology (AREA)
Pediatric Medicine (AREA)
Molecular Biology (AREA)
Mycology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Dairy Products (AREA)
Jellies, Jams, And Syrups (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines Containing Plant Substances (AREA)
Saccharide Compounds (AREA)

AT98912118T 1997-03-31 1998-03-30 Oligosaccharide enthaltende ernährungszusammensetzungen ATE326862T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US08/829,157 US6045854A (en)	1997-03-31	1997-03-31	Nutritional formulations containing oligosaccharides

Publications (1)

Publication Number	Publication Date
ATE326862T1 true ATE326862T1 (de)	2006-06-15

Family

ID=25253688

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT98912118T ATE326862T1 (de)	1997-03-31	1998-03-30	Oligosaccharide enthaltende ernährungszusammensetzungen

Country Status (12)

Country	Link
US (2)	US6045854A (de)
EP (1)	EP0975235B2 (de)
JP (2)	JP4863236B2 (de)
AT (1)	ATE326862T1 (de)
CA (1)	CA2285065C (de)
DE (1)	DE69834633T3 (de)
DK (1)	DK0975235T4 (de)
ES (1)	ES2265161T5 (de)
MX (1)	MX210206B (de)
NO (1)	NO315682B1 (de)
PT (1)	PT975235E (de)
WO (1)	WO1998043494A1 (de)

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19701382A1 (de) *	1997-01-16	1998-07-23	Nutricia Nv	Kohlenhydratmischung
US6329170B1 (en) *	1999-04-23	2001-12-11	Northwest Hospital	Nucleic acids and proteins of a rat ganglioside GM1-specific α1→2fucosyltransferase and uses thereof
DE19958985A1 (de) *	1999-12-07	2001-06-13	Nutricia Nv	Oligosaccharidmischung
EP1062873A1 (de) *	1999-12-13	2000-12-27	N.V. Nutricia	Verbessertes Säuglingsnährpräparat, Eiweisshydrolysat zur Verwendung in solchem Säuglingsnährpräparat, und Verfahren zur Herstellung solches Hydrolysates
JP2004527501A (ja)	2001-03-05	2004-09-09	ピー．アーネスト，スティーヴン	経腸処方
DE10147100A1 (de) *	2001-09-25	2003-04-17	Numico Res B V	Antiinfektive Kohlenhydrate
DE10204000A1 (de) *	2002-02-01	2003-08-14	Nutricia Nv	Sialysierte Kohlenhydrate
DE60336063D1 (de) *	2002-05-31	2011-03-31	Childrens Hosp Medical Center	Verfahren, zusammensetzung und kit für die antigenbindung von norwalk-ähnlichen viren
US7977098B2 (en) *	2002-05-31	2011-07-12	Children's Hospital Medical Center	Antigenic binding patterns of norovirus to human histo-blood group antigens
EP2272522B1 (de) *	2002-06-28	2017-09-06	Nestec S.A.	Therapeutische Zusammensetzungen zur Verwendung bei der Prophylaxe oder Behandlung von Diarrhö
CN1842277A (zh) *	2003-06-24	2006-10-04	堪萨斯大学医学中心	婴儿配方食品
MXPA06006392A (es) *	2003-12-05	2007-03-15	Childrens Hosp Medical Center	Composiciones de oligosacaridos y uso de estas en el tratamiento de infecciones.
ES1056525Y (es) *	2004-01-13	2004-07-16	Perez Alfredo Pineiro	Halador de tres rodillos para redes y aparejos de pesca.
DK1629850T4 (da) *	2004-08-24	2013-07-01	Nutricia Nv	Næringssammensætning indeholdende ufordøjelige oligosaccharider
RU2430631C2 (ru)	2006-02-10	2011-10-10	Нестек С.А.	Пребиотическая смесь олигосахаридов и пищевой продукт, ее содержащий
US20110152263A1 (en) *	2006-11-16	2011-06-23	Xi Jiang	Composition and method for inhibiting norovirus infection
US8197872B2 (en) *	2007-05-17	2012-06-12	The Regents Of The University Of California	Human milk oligosaccharides to promote growth of beneficial gut bacteria
JP5766947B2 (ja)	2007-09-07	2015-08-19	チルドレンズホスピタルメディカルセンター	臨床サンプルにおける分泌性のルイス抗原およびシアル化抗原のレベルの疾患リスクの予測指標としての使用
EP2060257A1 (de)	2007-11-08	2009-05-20	Nestec S.A.	Vorbeugung und Behandlung von Sekundärinfektionen nach Virusinfektion
AU2008324105B2 (en) *	2007-11-08	2014-01-30	Société des Produits Nestlé S.A.	Use of oligosaccharides containing N-acetyllactosamine for maturation of immune responses in neonates
EP2072052A1 (de)	2007-12-17	2009-06-24	Nestec S.A.	Verhinderung opportunistischer Infektionen bei Personen mit schwachem Immunsystem
PT2265135T (pt) *	2008-03-14	2018-02-21	Nestec Sa	Mistura simbiótica
ES2527959T3 (es) *	2008-12-02	2015-02-02	Prolacta Bioscience, Inc.	Composiciones de permeado de leche humana y métodos para realizarlas y usarlas
CA2743181A1 (en) *	2008-12-19	2010-06-24	Momenta Pharmaceuticals, Inc.	Methods related to modified glycans
EP2440582B1 (de)	2009-06-09	2018-11-07	Children's Hospital Medical Center	Monomere und dimere der antigen-norovirus-p-domäne, moleküle aus antigen-norovirus-partikeln sowie verfahren zu ihrer herstellung und verwendung
EP2451462B1 (de)	2009-07-06	2017-09-06	Children's Hospital Medical Center	Entzündungshemmung mit milch-oligosacchariden
MY189329A (en) *	2009-07-15	2022-02-04	Nutricia Nv	Mixture of non-digestible oligosaccharides for stimulating the immune system
WO2011136637A1 (en)	2010-04-27	2011-11-03	N.V. Nutricia	Use of human milk oligosaccharides in infant nutrition
PL2563166T3 (pl)	2010-04-27	2014-10-31	Nutricia Nv	Stosowanie oligosacharydów mleka ludzkiego w żywieniu niemowląt
WO2011150939A1 (en)	2010-06-01	2011-12-08	Glycom A/S	Polymorphs of 2'-o-fucosyllactose and producing thereof
EP2465509A1 (de) *	2010-11-23	2012-06-20	Nestec S.A.	Oligosaccharid Zusammensetzung zur Behandlung von akuten Atemwegsinfektionen
EP2454948A1 (de) *	2010-11-23	2012-05-23	Nestec S.A.	Oligosaccharidmischung und Lebensmittel mit dieser Mischung, insbesondere Säuglingsnahrung
SG191393A1 (en) *	2010-12-31	2013-08-30	Abbott Lab	Neutral human milk oligosaccharides to promote growth of beneficial bacteria
NZ612504A (en) *	2010-12-31	2015-02-27	Abbott Lab	Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
US9763970B2 (en)	2010-12-31	2017-09-19	Abbott Laboratories	Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
MY192208A (en) *	2010-12-31	2022-08-08	Abbott Lab	Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
NZ612386A (en) *	2010-12-31	2015-02-27	Abbott Lab	Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota
CN103391783A (zh) *	2010-12-31	2013-11-13	雅培制药有限公司	使用人乳寡糖改善呼吸道健康的方法
PH12013501382A1 (en) *	2010-12-31	2013-09-02	Abbott Lab0Ratories	Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers or children using human milk oligosaccharides
CA3114006C (en)	2010-12-31	2023-07-25	Abbott Laboratories	Human milk oligosaccharides for modulating inflammation
EP2522232A1 (de) *	2011-05-13	2012-11-14	Nestec S.A.	Nahrungsmittel mit menschlichen Milcholigosacchariden und Herstellungsverfahren dafür
US9567361B2 (en) *	2011-05-13	2017-02-14	Glycosyn LLC	Use of purified 2′-fucosyllactose, 3-fucosyllactose and lactodifucotetraose as prebiotics
EP2526784A1 (de)	2011-05-24	2012-11-28	Nestec S.A.	Milcholigosaccharid-Galactooligosaccharid-Zusammensetzung für Kindernahrung mit niedrigem Monosaccharidgehalt, enthaltend die in der Milch vorhandene lösliche Oligosaccharidfraktion, sowie ein Verfahren zur Herstellung der Zusammensetzung
CN107595860A (zh) *	2011-07-22	2018-01-19	雅培制药有限公司	用于预防胃肠道损伤和/或促进胃肠道修复的低聚半乳糖
EP2750523A1 (de) *	2011-08-29	2014-07-09	Abbott Laboratories	Galactooligosaccharide aus der muttermilch zur prävention von läsionen und/oder förderung der heilung des magen-darm-traktes
CN104812768B (zh) *	2012-11-13	2019-06-21	格礼卡姆股份公司	晶体3-o-岩藻糖基乳糖
US20150320780A1 (en) *	2012-12-14	2015-11-12	Glycom A/S	Mixture of fucosylate lactoses
EP2745705A1 (de) *	2012-12-18	2014-06-25	Abbott Laboratories	Ernährungsbedingte Verwendung von Muttermilch Oligosacchariden
WO2014130789A1 (en)	2013-02-21	2014-08-28	Children's Hospital Medical Center	Use of glycans and glycosyltransferases for diagnosing/monitoring inflammatory bowel disease
ES2891731T3 (es)	2013-05-22	2022-01-31	Glycom As	Mezcla sintética de oligosacáridos para el tratamiento de la microbiota de un mamífero
US9321803B2 (en)	2013-07-12	2016-04-26	Children's Hospital Medical Center	Compositions and methods for inhibiting norovirus infection
ES2856013T3 (es)	2013-11-15	2021-09-27	Nestle Sa	Composiciones para su uso en la prevención o tratamiento de infecciones del TRS en bebés o niños jóvenes en riesgo
HK1231398A1 (zh)	2014-04-08	2017-12-22	Abbott Laboratories	使用人乳寡糖增强对病原体的粘膜先天免疫反应和/或检测的方法
US10820616B2 (en)	2014-09-25	2020-11-03	Societe Des Produits Nestle S.A.	Infant formula system with adaptive levels of human milk oligosaccharides (HMOs)
DK3209673T4 (da)	2014-10-24	2023-10-02	Glycom As	Mixtures of human milk oligosaccharides
CN107105741A (zh) *	2014-10-31	2017-08-29	雀巢产品技术援助有限公司	用于促进脑发育和认知的包含fut2‑依赖性低聚糖和乳糖‑n‑新四糖的组合物
AU2016227600B2 (en)	2015-03-05	2020-05-21	Société des Produits Nestlé S.A.	Compositions for use in the prevention or treatment of gastrointestinal infections/inflammations in infants or young children
PH12017550044B1 (en)	2015-03-05	2022-04-27	SociaTa Des Produits Nestla S A	Compositions for use in the prevention or treatment of otitis or bronchitis in infants or young children
EP3288389A4 (de)	2015-04-28	2018-10-10	Children's Hospital Medical Center	Verwendung von oligosaccharidzusammensetzungen zur verstärkung der gewichtszunahme
WO2017021476A1 (en) *	2015-08-04	2017-02-09	Nestec S.A.	Nutritional compositions with 2fl and lnnt for use in inducing a gut microbiota close to the one of breast fed infants
BR112018010505B1 (pt)	2015-12-15	2021-11-16	Société des Produits Nestlé S.A.	Composições para bebês e crianças pequenas, e uso de uma mistura sintética de hmos
US11229231B2 (en) *	2016-01-26	2022-01-25	Societe Des Produits Nestle S.A.	Human milk oligosaccharides against later in life excessive fat mass accumulation and related health disorders
WO2017129648A1 (en) *	2016-01-26	2017-08-03	Nestec S.A.	Human milk oligosaccharides for health benefits by prevention of premature adiposity rebound
EP3515195A4 (de) *	2016-09-19	2020-05-27	Prolacta Bioscience, Inc.	Gereinigte oligosaccharide zusammensetzungen der menschlichen milch
US20180103675A1 (en)	2016-10-14	2018-04-19	Mead Johnson Nutrition Company	Personalized pediatric nutrition products comprising human milk oligosaccharides
US10980269B2 (en) *	2016-12-12	2021-04-20	Mead Johnson Nutrition Company	Protein hydrolysates and methods of making same
US11833198B2 (en)	2017-03-28	2023-12-05	Children's Hospital Medical Center	Norovirus S particle based vaccines and methods of making and using same
AU2018274636B2 (en)	2017-05-24	2024-05-02	Societe Des Produits Nestle S.A.	Composition comprising Human Milk Oligosaccharides (HMO) for use in the improvement of short term memory and other cognitive benefits
EP3629770A1 (de)	2017-05-24	2020-04-08	Société des Produits Nestlé S.A.	Zusammensetzung mit oligofructose (of) zur verwendung bei der verbesserung des kurzzeitgedächtnisses und anderer kognitiver vorteile
CN110868872A (zh) *	2017-07-07	2020-03-06	雀巢产品有限公司	人乳强化剂
EP3648618A1 (de) *	2017-07-07	2020-05-13	Société des Produits Nestlé S.A.	Verstärker für muttermilch
EP3648771A1 (de) *	2017-07-07	2020-05-13	Société des Produits Nestlé S.A.	Verstärker für muttermilch
US11197917B2 (en)	2017-12-01	2021-12-14	ByHeart, Inc.	Formulations for nutritional support in subjects in need thereof
EP3524067B1 (de)	2018-02-08	2025-04-02	Chr. Hansen HMO GmbH	Sprühgetrocknete mischung humaner milch-oligosaccharide
EP3546060A1 (de) *	2018-03-27	2019-10-02	DuPont Nutrition Biosciences ApS	Verfahren zur sprühtrocknung von fucosyllactoselösungen und verwandte produktzusammensetzungen
WO2019160922A1 (en) *	2018-02-19	2019-08-22	Dupont Nutrition Biosciences Aps	Process for spray drying fucosyllactose solutions and related product compositions
MY208468A (en)	2018-06-25	2025-05-11	Nestle Sa	Composition comprising human milk oligosaccharides for use in improving, enhancing, promoting or modulating a gabaergic function in the central nervous system
CN112384081B (zh)	2018-06-25	2024-05-24	雀巢产品有限公司	包含用于改善、增强、促进或调节中枢神经系统中血清素能功能的人乳低聚糖的组合物
MX2021006186A (es) *	2018-12-20	2021-06-18	Nestle Sa	Composicion fortificadora de leche humana.
EP3934656A1 (de) *	2019-03-05	2022-01-12	Société des Produits Nestlé S.A.	Ernährungszusammensetzung zur verwendung zur verbesserung einer ausführungsfunktion
US20220110985A1 (en) *	2019-06-04	2022-04-14	N.V. Nutricia	Nutritional composition comprising 2'fucosyllactose and 3'galactosyllactose
WO2021015977A1 (en) *	2019-07-23	2021-01-28	Dupont Nutrition Biosciences Aps	Oral healthcare treatment and related compositions
ES1240969Y (es) *	2019-09-18	2020-07-30	Jennewein Biotechnologie Gmbh	Composiciones de cereales que contienen oligosacaridos de la leche humana
AU2020354581A1 (en)	2019-09-24	2022-03-03	Prolacta Bioscience, Inc.	Compositions and methods for treatment of inflammatory and immune diseases
GB2590375B (en) *	2019-12-11	2024-05-08	Mjn Us Holdings Llc	Staged nutritional compositions containing human milk oligosaccharides and uses thereof
TW202233201A (zh)	2020-12-16	2022-09-01	荷蘭商弗里斯蘭康必奶荷蘭有限公司	包含ＬＮＦＰＩＩＩ和ＬＳＴａ的合成組成物
PL4346450T3 (pl)	2021-06-04	2025-06-09	N.V. Nutricia	Preparat do początkowego żywienia niemowląt do żywienia niemowląt otrzymujących preparat do początkowego żywienia niemowląt i mleko kobiece

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5951264B2 (ja) *	1981-11-30	1984-12-13	雪印乳業株式会社	オリゴ糖含有粉末の製造方法
DD273543A3 (de) *	1987-09-14	1989-11-22	Univ Rostock	Verfahren zur herstellung von saeuglings- und diaetnahrungen mit hypoantigener, bifidogener wirkung
SE462134B (sv) *	1987-10-22	1990-05-14	Biocarb Ab	Livsmedel innehaallande lacto-n-tetraos och foerfarande foer dess framstaellning
ATE83611T1 (de) *	1988-07-07	1993-01-15	Milupa Ag	Verfahren zur enzymatischen herstellung von bifidogener saeuglings- und diaetnahrung.
US5095106A (en) *	1989-07-25	1992-03-10	Colgate-Palmolive	Olgiosaccharide inhibition of Streptococcus pyogenes adhesion
US5180674A (en) *	1990-04-16	1993-01-19	The Trustees Of The University Of Pennsylvania	Saccharide compositions, methods and apparatus for their synthesis
US5021245A (en) *	1990-05-22	1991-06-04	Abbott Laboratories	Infant formula containing a soy polysaccharide fiber source
EP0785988A1 (de) *	1993-07-15	1997-07-30	Neose Pharmaceuticals, Inc	Verfahren zur synthese von saccharidzusammensetzungen
US5750176A (en) *	1994-03-09	1998-05-12	Abbott Laboratories	Transgenic non-human mammal milk comprising 2'-fucosyl-lactose
JPH0838064A (ja) *	1994-07-26	1996-02-13	Meiji Seika Kaisha Ltd	有害細菌の感染を予防する飼料
US5545553A (en) *	1994-09-26	1996-08-13	The Rockefeller University	Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
US5827526A (en) *	1995-07-11	1998-10-27	Abbott Laboratories	Use of indigestible oligosaccharides to prevent gastrointestinal infections and reduce duration of diarrhea in humans

1997
- 1997-03-31 US US08/829,157 patent/US6045854A/en not_active Expired - Lifetime
1998
- 1998-03-30 EP EP98912118.1A patent/EP0975235B2/de not_active Expired - Lifetime
- 1998-03-30 ES ES98912118.1T patent/ES2265161T5/es not_active Expired - Lifetime
- 1998-03-30 AT AT98912118T patent/ATE326862T1/de active
- 1998-03-30 WO PCT/US1998/006216 patent/WO1998043494A1/en not_active Ceased
- 1998-03-30 DE DE69834633.5T patent/DE69834633T3/de not_active Expired - Lifetime
- 1998-03-30 PT PT98912118T patent/PT975235E/pt unknown
- 1998-03-30 CA CA2285065A patent/CA2285065C/en not_active Expired - Lifetime
- 1998-03-30 DK DK98912118.1T patent/DK0975235T4/da active
- 1998-03-30 JP JP54189298A patent/JP4863236B2/ja not_active Expired - Fee Related
- 1998-12-18 US US09/216,056 patent/US6146670A/en not_active Expired - Lifetime
1999
- 1999-09-23 NO NO19994621A patent/NO315682B1/no not_active IP Right Cessation
- 1999-09-29 MX MX9908953A patent/MX210206B/es unknown
2011
- 2011-09-07 JP JP2011195159A patent/JP2012036192A/ja active Pending

Also Published As

Publication number	Publication date
MX210206B (es)	2002-09-06
EP0975235B2 (de)	2014-01-15
DE69834633T3 (de)	2014-05-08
CA2285065C (en)	2011-07-19
JP2012036192A (ja)	2012-02-23
US6045854A (en)	2000-04-04
EP0975235B1 (de)	2006-05-24
DE69834633T2 (de)	2007-05-03
DK0975235T4 (da)	2014-03-31
JP4863236B2 (ja)	2012-01-25
JP2001517949A (ja)	2001-10-09
WO1998043494A1 (en)	1998-10-08
DE69834633D1 (de)	2006-06-29
PT975235E (pt)	2006-10-31
US6146670A (en)	2000-11-14
CA2285065A1 (en)	1998-10-08
DK0975235T3 (da)	2006-10-02
NO994621D0 (no)	1999-09-23
NO315682B1 (no)	2003-10-13
ES2265161T5 (es)	2014-03-24
NO994621L (no)	1999-09-23
ES2265161T3 (es)	2007-02-01
EP0975235A1 (de)	2000-02-02
MX9908953A (es)	2000-01-31

Legal Events

Date

Code

Title

Description

2007-04-15

UEP

Publication of translation of european patent specification

Ref document number: 0975235

Country of ref document: EP

Publication	Publication Date	Title
ATE326862T1 (de)	2006-06-15	Oligosaccharide enthaltende ernährungszusammensetzungen
IL118047A (en)	2000-11-21	Sulfated oligosaccharides pharmaceutical compositions containing them and preparation of sulfated hexopyranose homooligosaccharides
NO20001105L (no)	2000-05-05	Transgene pattedyr som danner oligosakkarider i melken
PE44895A1 (es)	1995-12-20	Compuesto derivado de benzotiofeno que puede inhibir la perdida osea y disminuir el colesterol en suero
YU23599A (sh)	2001-07-10	Stabilizovani antihistaminski sirup
TNSN91070A1 (fr)	1992-10-25	Procede de preparation de derives de benzofuranne, bentothiophene indole ou indolizine ainsi que des compositions les contenant.
FI973828A0 (fi)	1997-09-29	Yhdisteitä ja koostumuksia aktiivisten aineiden annostelemiseksi
PL347671A1 (en)	2002-04-22	Compounds and compositions for delivering active agents
BG102259A (en)	1998-09-30	Compostions with controlled paroxetine release
WO2002051424A8 (en)	2002-08-01	Drugs against articular failure
ZA966964B (en)	1997-02-19	Compositions having synergistic fungitonix effects.
NZ516290A (en)	2004-03-26	Substituted phenoxyacetic acids
HUP9801133A3 (en)	2000-03-28	1,2,4-triazole-derivatives, fungicide compositions containing these compounds as active ingredients
CA2322229A1 (en)	2000-07-13	Compositions comprising heparin and soluble tnf receptors for inhibition of tnf activity
EP1075796A4 (de)	2002-07-17	Suesstoffzusammensetzung
EP1121932A4 (de)	2001-12-19	Heilmittel für augenerkrankungen
ES2183346T3 (es)	2003-03-16	Sistemas conjugados de bis-fosfonato con restos alquilantes que tienen actividad antitumoral.
ES2170377T3 (es)	2002-08-01	Composicion que contiene quitosana.
BG103779A (en)	2000-06-30	Crystallohydrate sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidine-3-ilidenmethyl)-1h-i ndole-2-carboxylic acid
AU7365596A (en)	1997-04-09	Nisin compositions to prevent the promotion of tooth decay bysuppressing formation of acid from foods by oral bacteria
GB2314507A (en)	1998-01-07	Anti-emetic pharmaceutical compositions containing methotrimeprazine
CA2183745A1 (en)	1995-09-28	Detergent Compositions
MX9802136A (es)	1998-08-30	Composiciones detergentes.
IT1254324B (it)	1995-09-14	Soluzioni campione di cianuro stabili all'immagazzinamento
CO4340677A1 (es)	1996-07-30	Formulaciones novedosas conteniendo paroxetina